Related Experiment Video
Updated: Feb 2, 2026

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells
Published on: February 12, 2021
FosB mRNA Expression in Peripheral Blood Lymphocytes in Drug Addicted Patients
Quézia Silva Anders1, Jaisa Klauss1, Livia Carla de Melo Rodrigues2
1Laboratory of Cognitive Sciences and Neuropsychopharmacology, Program of Post-Graduation in Physiological Sciences, Health Sciences Center, Federal University of Espírito Santo, Vitória, Brazil.
Abstract:
FosB gene heterodimerizes with Jun family proteins to form activator protein 1 (AP-1) complexes that bind to AP-1 sites in responsive genes to regulate transcription in all cells. The genic expression of FosB seems to be modified after long time exposure to drugs of abuse and these changes may be involved in craving and addicted behavior. This study investigated the FosB mRNA expression in peripheral blood lymphocytes of drug addicted patients using real-time PCR approach. Thus, patients with crack-cocaine use disorder (CUD, n = 10), alcohol use disorder (AUD, n = 12), and healthy non-addicted subjects (CONT, n = 12) were assessed. FosB mRNA expression was reduced by 1.15-fold in CUD and 2.17-fold in AUD when compared to CONT. Hedge's effect size gs over log FosB/Act was of 0.66 for CUD and of 0.30 for AUD when compared to controls. This study showed that FosB mRNA expression was detected in lymphocytes from peripheral blood for the first time, and it was less expressed in drug addicted patients. This molecular technique may constitute a potential peripheral marker for substance use disorder.
Insights
FosB gene expression in lymphocytes was lower in individuals with crack-cocaine use disorder and alcohol use disorder compared to healthy controls. This finding suggests FosB mRNA may serve as a biomarker for substance use disorders.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- The FosB gene plays a role in transcriptional regulation via activator protein 1 (AP-1) complexes.
- Altered FosB gene expression is implicated in the neurobiological adaptations associated with drug addiction and craving.
- Investigating peripheral markers for substance use disorders is crucial for diagnostic and therapeutic advancements.
Purpose of the Study:
- To quantify FosB mRNA expression in peripheral blood lymphocytes of individuals with substance use disorders.
- To determine if FosB mRNA levels differ between patients with crack-cocaine use disorder (CUD), alcohol use disorder (AUD), and healthy controls (CONT).
- To explore the potential of FosB mRNA as a peripheral biomarker for substance use disorders.
Main Methods:
- Real-time quantitative polymerase chain reaction (qPCR) was employed to measure FosB mRNA expression.
- Peripheral blood lymphocytes were collected from patients diagnosed with CUD (n=10), AUD (n=12), and healthy controls (n=12).
- Statistical analysis included fold change calculations and Hedge's effect size (g_s) to compare gene expression levels.
Main Results:
- FosB mRNA expression was detected in peripheral blood lymphocytes, a novel finding.
- A 1.15-fold reduction in FosB mRNA was observed in CUD patients compared to controls.
- A significant 2.17-fold reduction in FosB mRNA was found in AUD patients compared to controls.
- Effect sizes indicated moderate (CUD) to small (AUD) differences in FosB mRNA expression relative to controls.
Conclusions:
- FosB mRNA is expressed in human peripheral blood lymphocytes.
- Drug addiction, specifically CUD and AUD, is associated with reduced FosB mRNA expression in lymphocytes.
- Lymphocyte FosB mRNA levels represent a potential peripheral biomarker for identifying substance use disorders.
Related Concept Videos
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
mRNA Stability and Gene Expression
Drug Abuse and Addiction: Pharmacological Phenomena
Drug Dosing: Geriatric Patients
Regulated mRNA Transport
Drug Dosing: Obese Patients

